Longitudinal Assessment of HES1 Promoter Methylation Dynamics in Preterm Versus Term Newborns: A Potential Indicator of Neurodevelopmental Alterations

Vol 1, 2025 - 329942
Poster
Favorite this paper
How to cite this paper?
Abstract

Background: Approximately 10% of live births worldwide are preterm, interrupting critical neurodevelopmental processes that normally occur during the last trimester. HES1, a transcriptional regulator of neural progenitor cell maintenance and differentiation, may undergo aberrant DNA methylation in preterm infants, potentially marking early neurodevelopmental perturbations.

Objective: This study aimed to profile HES1 promoter methylation over the first three months of life in preterm and term newborns and to assess its potential as an epigenetic biomarker for early neurodevelopmental alterations.

Methods: In a prospective longitudinal design, 49 term and 46 preterm infants were enrolled at the Maternity School of UFRJ. Cord blood was sampled at birth (D0) for both groups; peripheral blood was collected at day 5 (D5) for all infants and additionally at days 30 (D30) and 90 (D90) for preterm infants. After DNA extraction and bisulfite conversion, nine CpG sites within the HES1 promoter region (Chr3:193,849,141–193,849,361) were amplified by PCR and quantified via pyrosequencing on a PyroMark Q48. Methylation levels were compared between groups at each time point using Mann–Whitney U tests, and temporal trends in preterm infants were evaluated with generalized linear models.

Results: At D0, preterm infants exhibited significantly lower methylation across all nine CpG sites compared to term controls (all p < 0.05). By D5, methylation in preterm infants partially converged toward term levels, although differences remained at several sites. Persistent hypomethylation at D30 and D90 (mean Δ methylation ≥ 5% at multiple CpGs) indicated enduring epigenetic divergence.

Conclusions: HES1 promoter hypomethylation is evident immediately after preterm birth and persists through three months of age. These methylation dynamics may serve as a potential early biomarker of neurodevelopmental alterations, highlighting a critical window for epigenetic intervention in the NICU.

 

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 D’Or Institute for Research and Education
Track
  • PhD (Doctorate)
Keywords
Prematurity
DNA Methylation
HES1 Gene
Neurodevelopment
Epigenetic Biomarker